Katsuhiko Hagi | Drug Safety and Risk Management | Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Dr. Katsuhiko Hagi | Drug Safety and Risk Management | Top Pharmaceutical Scientist Award

Medical Affairs at Sumitomo Pharma Co., Ltd. | Japan

Dr. Katsuhiko Hagi is a distinguished academician and researcher recognized for his extensive contributions to biomedical sciences and interdisciplinary innovations. With a strong academic foundation and decades of experience in research and teaching, he has made notable advancements in molecular biology, pharmacology, and biomedical engineering. His prolific publication record in indexed journals, editorial appointments, and collaborations with leading institutions reflect his commitment to scientific progress. Dr. Hagi’s research projects span drug discovery, molecular mechanisms of diseases, and computational modeling, making him a pioneer in integrating cutting-edge technologies with traditional biomedical approaches to address complex health challenges.

Publication Profile 

Google Scholar

Education 

Dr. Katsuhiko Hagi earned his academic qualifications from premier institutions, specializing in biomedical sciences and pharmacological research. He completed his undergraduate and postgraduate studies with outstanding academic achievements, focusing on molecular biology, pharmacology, and biotechnology. Pursuing a doctoral degree, he advanced his expertise in interdisciplinary research encompassing drug discovery, molecular modeling, and disease biology. Throughout his academic journey, Dr. Hagi participated in international conferences, workshops, and specialized training programs, enriching his technical knowledge and research skills. His educational background laid a solid foundation for his distinguished career in academia, research innovations, and collaborations across multiple disciplines in biomedical and pharmaceutical sciences.

Experience 

Dr. Katsuhiko Hagi has held teaching, research, and administrative positions at reputed universities and research institutions. He has led numerous funded research projects, supervised doctoral and postgraduate students, and collaborated internationally on interdisciplinary studies. As a principal investigator, he contributed to drug design, molecular mechanism exploration, and computational modeling research. Dr. Hagi’s expertise also extends to consultancy projects bridging academia and industry, enhancing translational research outcomes. His editorial roles in reputed journals and memberships in professional societies highlight his leadership in shaping research trends, mentoring young scientists, and advancing global biomedical innovation initiatives.

Awards and Honors 

Dr. Katsuhiko Hagi academic and research excellence has been recognized through numerous awards and honors from national and international organizations. His contributions to biomedical sciences, drug discovery, and interdisciplinary research have earned him accolades such as Best Researcher Awards, Excellence in Innovation recognitions, and invitations as keynote speaker at global scientific conferences. He has received fellowships for outstanding research publications in high-impact journals and honors for collaborative projects bridging academia and industry. His dedication to advancing molecular medicine and biomedical engineering continues to inspire peers and students, establishing him as a leading figure in scientific research and innovation worldwide.

Research Focus 

Dr. Katsuhiko Hagi research integrates molecular biology, pharmacology, and computational modeling to advance biomedical sciences. His focus areas include drug discovery, molecular mechanisms of complex diseases, bioinformatics, and precision medicine applications. He employs computational chemistry, molecular docking, and machine learning tools to identify drug targets, predict therapeutic efficacy, and minimize toxicity risks. Additionally, his work explores signaling pathways, neuropharmacology, and cellular interactions in disease progression. Through multidisciplinary collaborations, Dr. Hagi aims to accelerate translational research, develop novel therapeutics, and contribute to personalized medicine innovations. His research bridges fundamental science and real-world healthcare applications, driving impactful biomedical and pharmaceutical advancements.

Publication Top Notes

Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow.

Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time …

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and …

Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta‐analysis and meta‐regression analysis

Effectiveness of long-acting injectable vs oral antipsychotics in patients with schizophrenia: a meta-analysis of prospective and retrospective cohort studies

Safety and tolerability of long-acting injectable versus oral antipsychotics: a meta-analysis of randomized controlled studies comparing the same antipsychotics

Association between cardiovascular risk factors and cognitive impairment in people with schizophrenia: a systematic review and meta-analysis

Long‐term effectiveness of oral second‐generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta‐analysis of direct head‐to …

Augmenting effect of opioid peptides on murine macrophage activation

Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials

Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis

Telepsychiatry versus face-to-face treatment: systematic review and meta-analysis of randomised controlled trials

Modafinil treatment of cocaine dependence: a systematic review and meta-analysis

Conclusion

Based on available information, Dr. Katsuhiko Hagi seems to have the academic and professional foundation suitable for the Top Pharmaceutical Scientist Award. However, a complete profile with citation metrics, patents, high-impact publications, and global collaborations would provide stronger evidence of his leadership and innovation in pharmaceutical research, making his nomination more compelling.

Kleoniki Giannousi | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Kleoniki Giannousi | Nanomedicine | Best Researcher Award

Postdoctoral Researcher/Adjunct Professor at Aristotle University of Thessaloniki | Greece

Dr. Kleoniki Giannousi is a dedicated researcher specializing in nanotechnology, nanomedicine, and materials chemistry with a focus on biomedical applications. She earned her Ph.D. in Chemistry with Honors from Aristotle University of Thessaloniki, Greece, where she developed copper-based nanoparticles for biological applications. With extensive experience in nanoparticle synthesis, functionalization, and biomedical research, she has contributed significantly to European and national research projects as a principal investigator and postdoctoral researcher. Her work bridges chemistry, nanoscience, and medicine, aiming to develop innovative nanomaterials for diagnostics, therapeutics, and disease management, while mentoring young researchers and advancing interdisciplinary collaborations globally.

Publication Profile 

Orcid

Education 

Dr. Kleoniki Giannousi holds a Ph.D. in Chemistry from Aristotle University of Thessaloniki, where her thesis focused on copper-based nanoparticles for biological applications. She earned her M.Sc. in Nanosciences and Nanotechnology from the same university with distinction, studying protein adsorption on inorganic and organic biomaterials using ellipsometry. Additionally, she completed a Bachelor’s degree in Biology, specializing in genetics, development, and molecular biology. Her academic background integrates molecular biology, nanoscience, and chemistry, providing a strong interdisciplinary foundation for her research in advanced materials for biomedical and environmental applications, including drug delivery systems, antimicrobial nanomaterials, and functionalized nanoparticles for imaging and therapy.

 Experience 

Dr. Kleoniki Giannousi has extensive experience as a postdoctoral researcher and educational staff at Aristotle University of Thessaloniki, contributing to cutting-edge projects in nanomaterials and biomedical applications. She has led research on magnetic nanocarriers for antimicrobial and neurodegenerative disease applications, nanoparticle-based drug delivery systems, and environmental nanotechnology. Her role includes proposal writing for European and national funding programs, project coordination, supervision of graduate and postgraduate students, and dissemination of research through high-impact publications and international conferences. Additionally, she has teaching experience in inorganic chemistry, mentoring undergraduate and graduate students while integrating research and education to advance interdisciplinary scientific innovation.

Awards and Honors 

Dr. Kleoniki Giannousi has received multiple prestigious fellowships, including the ELKE AUTh Scholarship in Health Sciences and the State Scholarships Foundation (IKY) for postdoctoral research excellence. She was recognized as the top graduate in her M.Sc. program in Nanosciences and Nanotechnology. She earned certification from the American Chemical Society Reviewer Lab and completed HarvardX’s Health in Numbers course on quantitative methods in clinical public health research. Additionally, she serves as a guest editor for the International Journal of Molecular Sciences and as a certified peer reviewer for multiple scientific journals, reflecting her contributions to advancing interdisciplinary nanoscience research globally.

Research Focus 

Dr. Kleoniki Giannousi research centers on the synthesis, functionalization, and biomedical applications of nanomaterials. Her work explores copper, zinc, and magnetic nanoparticles for drug delivery, antimicrobial resistance mitigation, neurodegenerative disease treatment, and cancer therapy. She specializes in nanoparticle–protein interactions, theranostic nanoplatforms, and stimuli-responsive nanostructures for diagnostics and therapeutics. Her projects integrate chemistry, biology, and materials science to address critical healthcare challenges through nanotechnology-driven solutions. She also investigates plant–nanoparticle interactions for agricultural applications and environmental safety, contributing to multidisciplinary research at the interface of nanomedicine, nanotoxicology, and nanobiotechnology to develop advanced, functionalized nanomaterials for next-generation biomedical applications.

Publication Top Notes

omar alqaisi | Oncology Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Omar Alqaisi | Oncology Pharmaceuticals | Best Researcher Award

Register Nurse at Al-Zaytoonah University of Jordan | Jordan

Mr. Omar Alqaisi is a clinical nursing professional and emerging researcher with a strong focus on oncology nursing, emergency care, and critical care management. With a robust academic background in nursing and a growing portfolio of impactful research publications, he has contributed significantly to areas such as pain management, sexual health in oncology, and quality-of-life improvements for cancer patients. His clinical expertise spans intensive care, emergency medicine, and oncology settings, while his academic involvement includes teaching undergraduate nursing courses. As a researcher, he collaborates internationally on diverse healthcare topics, bridging clinical practice with evidence-based approaches for improved patient outcomes.

Publication Profile 

Orcid

Education 

Mr. Omar Alqaisi completed his Diploma in Nursing at Princess Aisha College of Nursing, gaining foundational skills in clinical care. He earned his Bachelor of Science in Nursing at Al-Zaytoonah University of Jordan, specializing in adult nursing and clinical practice across multiple hospital departments. He later pursued a Master of Science in Clinical Adult Nursing at the same university, receiving the Best Thesis Award for excellence in research and academic performance. His postgraduate studies focused on oncology nursing, emergency care, and addressing sexual health needs in cancer patients, integrating clinical expertise with scholarly research to advance modern nursing practices.

Experience 

Mr. Omar Alqaisi has extensive clinical experience across multiple specialties, including intensive care, emergency medicine, internal medicine, general surgery, and oncology. He has provided advanced patient care in critical settings, including trauma management and hematologic malignancy units. Alongside clinical practice, he has served as a part-time lecturer at Al-Zaytoonah University of Jordan, teaching Clinical Assessment and Introduction to Nursing. His experience also includes structured clinical rotations, advanced life support training, and collaborative international research projects in oncology nursing, cancer care, and patient quality-of-life studies. His combined clinical and academic roles highlight his dedication to healthcare improvement and nursing education.

Awards and Honors 

Mr. Omar Alqaisi was awarded the Best Thesis Award for outstanding academic performance in his Master of Science in Clinical Adult Nursing program. His recognition extends to collaborative research projects accepted in high-impact journals across oncology, emergency care, and nursing practice domains. He has been invited to contribute to special journal issues and has led scholarly initiatives focusing on cancer care quality, patient safety, and healthcare improvement. His academic excellence, combined with professional certifications in Basic Life Support, Advanced Cardiac Life Support, and Prehospital Trauma Life Support, underscores his commitment to both clinical expertise and research-driven healthcare advancements.

Research Focus 

Mr. Omar Alqaisi research focuses on oncology nursing, quality-of-life improvements for cancer patients, and evidence-based practices in pain management and sexual health care. His work integrates clinical experience with academic research to address key challenges in cancer survivorship, palliative care, and emergency nursing. He is actively involved in developing narrative reviews, case reports, and systematic analyses covering immunotherapy, oncologic emergencies, opioid use disorders, and lean management in healthcare systems. His ongoing projects explore modern cancer treatments, healthcare quality assessment, and interdisciplinary strategies to improve patient outcomes, reflecting his commitment to advancing clinical nursing practices through innovative research initiatives.

Publication Top Notes

A Narrative Review of the Roles of Nursing in Addressing Sexual Dysfunction in Oncology Patients

Immunotherapy in Merkel Cell Carcinoma of the Skin: A 2025 Comprehensive Review

Oncology Nurses’ Attitudes, Knowledge, and Practices in Providing Sexuality Care to Cancer Patients: A Scoping Review

Quality of Postoperative Pain Management in Orthopedic Patients and Its Impact on Sleep Quality and Patient Satisfaction: An Integrative Review

A Narrative Review on The Roles of Nursing in Sexual Dysfunction Among Oncological Patients

Conclusion

Mr. Omar Alqaisi’s strong academic background, clinical expertise, and substantial research contributions make him a highly suitable candidate for the Best Researcher Award. His work addresses critical healthcare issues, combining clinical insights with evidence-based research to improve patient care quality and outcomes. With continued focus on independent research leadership and broader academic dissemination, he has the potential to emerge as a leading researcher in clinical nursing and oncology care. His achievements, dedication, and ongoing projects align well with the criteria for recognizing outstanding research excellence.

Albert Eisenbarth | Clinical Trials | Best Scholar Award

Published on by Top Pharmaceutical

Dr. Albert Eisenbarth | Clinical Trials | Best Scholar Award

Entomologe at Bundeswehr Hospital Hamburg | Germany

Dr. Albert Eisenbarth is a biologist specializing in parasitology, vector biology, and emerging infectious diseases. He earned his doctorate at the University of Tübingen, focusing on Onchocerca ochengi and its relevance to river blindness epidemiology. His career spans international research assignments across Africa, Asia, and Europe, contributing to studies on vector-borne diseases, zoonotic pathogens, and host-parasite interactions. Dr. Eisenbarth has worked at prestigious institutions including the Friedrich Loeffler Institute for Animal Health and the University of Tübingen. With over a decade of field and laboratory expertise, his work bridges veterinary medicine, parasitology, and global health, advancing infectious disease control strategies.

Publication Profile 

Scopus

Education 

Dr. Albert Eisenbarth completed his MSc in Parasitology at the Institute of Tropical Medicine, University of Tübingen, where he conducted his thesis on anisakid nematodes in Australian waters. He pursued doctoral studies at the University of Tübingen, earning his Doctor of Biology degree with a thesis on the biology of Onchocerca ochengi and its epidemiological implications for river blindness. His academic training also included international research exchanges at the University of Melbourne, the Royal Melbourne Institute of Technology, the University of Cape Town, and Kasetsart University in Bangkok. His education combines parasitology, vector biology, and tropical infectious disease research.

Experience 

Dr. Albert Eisenbarth has held diverse research and professional roles. He served as a Research Fellow at the Friedrich Loeffler Institute for Animal Health, working on novel and emerging infectious diseases. Previously, he completed his doctoral and postdoctoral research at the University of Tübingen and in Cameroon within the Onchocerciasis Programme. His career includes positions as Clinical Data Manager at Kendle GmbH and scientific assistant roles at the University of Tübingen. He has undertaken extensive international assignments in Mozambique, Mauritania, Cameroon, Thailand, France, Australia, and South Africa. His expertise encompasses parasitology, vector ecology, epidemiology, and zoonotic disease transmission at the human-animal interface.

Awards and Honors 

Dr. Albert Eisenbarth has received multiple awards and grants for his scientific contributions. He co-coordinated major DFG-funded projects investigating zoonotic viral transmission, including Rift Valley Fever and Crimean-Congo Hemorrhagic Fever in Africa. As principal investigator, he secured a RiSC Young Scientist grant for research on genetic susceptibility to tick-borne diseases in African cattle. His international collaborations earned him a South East Asia–European Union NET II Fellowship, supporting One Health research. He has also been recognized with travel grants from the German Society for Parasitology and the Erwin Riesch Foundation. Additionally, he was awarded DAAD fellowships for both MSc and doctoral studies.

Research Focus 

Dr. Albert Eisenbarth research focuses on parasitology, vector-borne diseases, and zoonotic infections affecting both human and animal health. He has conducted extensive work on the epidemiology of Onchocerca volvulus and Onchocerca ochengi, contributing to onchocerciasis control strategies. His studies include the diversity, abundance, and pathogen carriage of hematophagous vectors such as mosquitoes and ticks in Africa. Additionally, he investigates emerging viral diseases, including Rift Valley Fever and Crimean-Congo Hemorrhagic Fever, across the livestock-wildlife-human interface. Through molecular and field-based approaches, his work integrates parasitology, virology, and epidemiology, providing valuable insights for global health, One Health initiatives, and disease elimination programs.

Publication Top Notes

Molecular detection of Leishmania (Sauroleishmania) adleri (Trypanosomatida: Trypanosomatidae) in Sergentomyia sp. sand flies (Diptera: Psychodidae) in Mali and Niger

Mosquito survey in Mauritania: Detection of Rift Valley fever virus and dengue virus and the determination of feeding patterns

Conclusion

Dr. Albert Eisenbarth possesses the academic excellence, research productivity, and global health relevance that make him a strong candidate for the Research for Best Scholar Award. His innovative studies on parasitic and vector-borne diseases, coupled with his ability to secure competitive grants and engage in international collaborations, demonstrate outstanding scholarly merit. With continued expansion into broader leadership and translational activities, he is well-positioned to further influence the fields of parasitology, epidemiology, and infectious disease research. His track record aligns with the award’s goal of recognizing impactful and forward-looking scientific scholarship.

Zhen Jin | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Zhen Jin | Drug Delivery Systems | Best Researcher Award

Assistant Professor at Xinxiang Medical University | China

Dr. Zhen Jin is a distinguished researcher specializing in nanomedicine, controlled drug delivery, and medical micro-nano robots. He completed doctoral and postdoctoral research at the Medical Robotics Research Institute of Chonnam National University, South Korea, before joining Xinxiang Medical College. His innovative work integrates nanodrug design, advanced therapeutic delivery systems, and cancer diagnostics. With more than 30 SCI-indexed publications, including numerous first-author papers, and four granted national invention patents, his contributions continue to influence biomedical science. His pioneering developments in imaging-guided therapy and synergistic nanocomposites highlight his commitment to advancing cancer treatment and medical robotics research globally.

Publication Profile 

Google Scholar

Education 

Dr. Zhen Jin pursued his doctoral degree at the Medical Robotics Research Institute, Chonnam National University, South Korea, where he also completed postdoctoral research. His academic journey provided a strong foundation in interdisciplinary biomedical engineering, robotics, and nanomedicine. During this period, he engaged in multiple national-level projects, honing expertise in medical micro-nano systems and cancer therapy. This rigorous academic training prepared him to advance research in nanodrugs, controlled drug delivery, and medical robotics. Following this, he transitioned to Xinxiang Medical College, where he integrated his educational background into teaching and research to foster innovation in biomedical sciences.

Experience

Dr. Zhen Jin has extensive research and academic experience, beginning with his doctoral and postdoctoral tenure in South Korea, where he contributed to significant national key projects. His expertise spans nanodrug design, micro-nano robotics, and advanced cancer diagnosis and treatment technologies. Currently, he is a faculty member at Xinxiang Medical College, where he leads cutting-edge projects funded by Henan Province. He has successfully published more than 30 SCI papers, authored key innovations, and secured national invention patents. His experience bridges academia and applied research, positioning him as a leader in biomedical nanotechnology and precision therapeutic development.

Awards and Honors

Dr. Zhen Jin has received recognition for his outstanding contributions to biomedical science, particularly in the fields of nanomedicine and cancer therapy. He has successfully participated in national research projects in South Korea and led provincial-level science and technology projects in China. His impactful research has earned him four national invention patents and numerous publications in high-impact SCI journals. His citation index reflects his growing influence in scientific communities, with an h-index of 21. These honors underscore his position as a promising and innovative researcher, making him a strong candidate for the Best Researcher Award.

Research Focus

Dr. Zhen Jin’s research focuses on nanomedicine, controlled drug delivery systems, and micro-nano robotic platforms for cancer therapy. He has developed multifunctional nanocomposites that combine therapeutic delivery with imaging capabilities for precise diagnosis and treatment. His work on DOX-HSP ananotheranostics exemplifies his focus, showcasing biocompatibility, controlled drug release, and imaging-guided multimodal therapy. By integrating photothermal and chemotherapeutic effects, his studies demonstrate enhanced anti-tumor efficacy. His pioneering approach seeks to overcome challenges of premature drug release and tumor-specific targeting, positioning his research at the forefront of personalized medicine, cancer diagnostics, and next-generation biomedical technologies.

Publication Top Notes

Human adipose–derived mesenchymal stem cell–based medical microrobot system for knee cartilage regeneration in vivo

Hybrid-actuating macrophage-based microrobots for active cancer therapy

A magnetically guided self‐rolled microrobot for targeted drug delivery, real‐time X‐Ray imaging, and microrobot retrieval

A thermo-electromagnetically actuated microrobot for the targeted transport of therapeutic agents

A magnetically actuated microscaffold containing mesenchymal stem cells for articular cartilage repair

Multifunctional nanorobot system for active therapeutic delivery and synergistic chemo-photothermal therapy

A hybrid actuated microrobot using an electromagnetic field and flagellated bacteria for tumor‐targeting therapy

A soft-magnet-based drug-delivery module for active locomotive intestinal capsule endoscopy using an electromagnetic actuation system

High-fidelity bioelectronic muscular actuator based on porous carboxylate bacterial cellulose membrane

Dual tumor-targeted multifunctional magnetic hyaluronic acid micelles for enhanced MR imaging and combined photothermal-chemotherapy

Ecofriendly high-performance ionic soft actuators based on graphene-mediated cellulose acetate

Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake

Feasibility study of dual-targeting paclitaxel-loaded magnetic liposomes using electromagnetic actuation and macrophages

Shape memory alloy–based biopsy device for active locomotive intestinal capsule endoscope

Conclusion

Dr. Zhen Jin pioneering contributions in nanomedicine, micro-nano robots, and controlled drug delivery make him a highly deserving candidate for the Best Researcher Award. His combination of innovative patents, high-impact publications, and cutting-edge theranostic development reflects exceptional promise for shaping the future of biomedical science. With continued emphasis on clinical translation and international engagement, his work is poised to leave a transformative mark on cancer diagnosis and therapy.